Company Filing History:
Years Active: 2010-2021
Title: Catherine E Lofton-Day: Innovator in Cellular Proliferative Disorders
Introduction
Catherine E Lofton-Day is a notable inventor based in Seattle, WA. With an impressive portfolio of 12 patents, she has significantly contributed to the field of molecular biology, specifically in the analysis and treatment of cellular proliferative disorders. Her innovative approaches have impactful implications for diagnostics and patient care.
Latest Patents
Catherine's latest patents showcase her expertise in genomic research. One of her significant inventions, "Methods and nucleic acids for analyses of cellular proliferative disorders," provides advanced methods and kits designed to detect and differentiate between liver and colorectal cell proliferative disorders. This innovation reveals genomic sequences and methylation patterns that enhance the accuracy of diagnoses and improve treatment options for patients.
Another notable patent, "Method for determining the presence or absence of methylation in a sample," encompasses unique methods for analyzing DNA extracted from remote samples. This technology allows for precise differentiation between methylated and unmethylated cytosines, contributing to advancements in methylation analysis of DNA from various human samples, including blood and urine.
Career Highlights
Catherine E Lofton-Day currently works with Epigenomics AG, a company focused on innovating solutions in the field of molecular diagnostics. Her work has placed her at the forefront of research regarding cellular proliferative disorders, establishing her as a leading figure in her field.
Collaborations
Throughout her career, Catherine has collaborated with esteemed colleagues, including Andrew Z Sledziewski and Reimo Tetzner. These collaborations have furthered her research efforts and expanded her innovative capabilities within her specialized field.
Conclusion
Catherine E Lofton-Day's contributions to the field of cellular biology and her impressive array of patents exemplify her dedication to enhancing medical diagnostics and treatment. Her work continues to influence research and practices within the healthcare sector, making a significant impact on patient outcomes.